IVAX CORP /DE
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: IVAX CORP /DE, 10-Q, EX-10.18, 2000-08-14
Next: EQUINOX SYSTEMS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM IVAX
CORPORATION'S FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                                   1,000

<S>                                            <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                             269,703
<SECURITIES>                                             0
<RECEIVABLES>                                      135,095
<ALLOWANCES>                                        21,451
<INVENTORY>                                        172,774
<CURRENT-ASSETS>                                   591,113
<PP&E>                                             384,073
<DEPRECIATION>                                     158,634
<TOTAL-ASSETS>                                     943,278
<CURRENT-LIABILITIES>                              206,841
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                            15,838
<OTHER-SE>                                         451,050
<TOTAL-LIABILITY-AND-EQUITY>                       943,278
<SALES>                                            322,027
<TOTAL-REVENUES>                                   366,543
<CGS>                                              185,871
<TOTAL-COSTS>                                      185,871
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                       550
<INTEREST-EXPENSE>                                   7,245
<INCOME-PRETAX>                                     64,603
<INCOME-TAX>                                         6,186
<INCOME-CONTINUING>                                 57,979
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                     (2,254)
<CHANGES>                                                0
<NET-INCOME>                                        55,725
<EPS-BASIC>                                            .36
<EPS-DILUTED>                                          .34



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission